SOURCE: BDI Pharma, Inc.

BDI Pharma, Inc.

April 14, 2010 08:00 ET

Biotech Distributor BDI Pharma, Inc. Announces Record Revenue Pace

COLUMBIA, SC--(Marketwire - April 14, 2010) -  BDI Pharma, Inc. (BDI), the fastest growing national distributor of biotech therapies, announced that sales for the first quarter of 2010 represented an increase of more than nineteen percent (19%) in comparison to the same time period in 2009. In posting record sales revenue numbers, the company demonstrated notable expansion in three of the company's key product classifications -- Specialty Biopharmaceuticals, Protein Biotherapeutics and Vaccines. Significant revenue growth was achieved specifically in the clinical areas of Oncology and Hemophilia.

"The gains which BDI has experienced this first quarter truly represent the successful implementation and execution of the corporate programming, concepts and initiatives we continue to develop in accord with the ever-changing healthcare landscape," said Edward Stiefel, Jr., Co-President. "Regardless of variable market shifts and economic pressures, we have always strived to provide service-oriented solutions to our customers, as well as to our trade partners. The results of this past quarter stand as testament to the effectiveness of that mentality."

About BDI Pharma, Inc.

Serving the healthcare community since 1995, BDI Pharma, Inc. has built an outstanding reputation as an industry source for products and service. BDI Pharma's market focus is evident in its commitment to specialty biotherapeutics, chemotherapies, vaccines and plasma protein therapies, including Albumin, intravenous immune globulin (IVIG or IGIV), coagulation factors VIII, IX, and VIIa, hyper-immunes, and injectables. As a manufacturer recognized Authorized Distributor of Record, BDI Pharma, Inc. services the entire country and is fully accredited and insured, fulfilling the licensing requirements in all 50 states.

In an arena where access to pertinent clinical data and updated information on market availability is paramount to patient care, BDI Pharma, Inc. defines its customer-centric approach to serving the nation's healthcare community through innovative inventory management programs, unparalleled customer service, extensive product knowledge, unique promotional services, emergency availability and urgent need delivery. The company serves as a source for reference material and market data, offering healthcare providers the latest information on products, supply and other industry events. BDI Pharma, Inc.'s educational literature and Web site -- -- serve as open-access resources, contributing to the promotion of the biopharmaceutical industry and the education of both the healthcare community and general populace.

Contact Information

  • Contact:
    Brad Davis
    VP, Marketing
    (800) 948-9834